Skip to main content

Site notifications

AusPAR: Nivolumab

Australian Public Assessment Report
Device/Product Name
Opdivo
Active ingredients
Nivolumab
AusPAR Date
Published
Submission Number
PM-2017-02209-1-4
Submission Type
Major variation (new indication)
Decision
Approved

Help us improve the Therapeutic Goods Administration site